The selective domination of either DR4 or DR5 in a particular cancer type has not been thoroughly established however, previous studies suggest the prominence of DR4 in colon and breast cancers while DR5 is better correlated as a target for GBM27–32. This evidence concerns the gene TNFRSF10B and breast carcinoma.